Health Policy Working Group: Keith Finlay
"Willingness-to-Pay for Pharmaceutical Retail Convenience: Evidence from a Contingent"
Assistant Professor of Economics
More Information
About The Speaker
Dr. Finlay received his PhD from University of California, Irvine in 2007. His research fields are labor economics and applied econometrics, and his research interests include external effects of incarceration and crime and human capital in cities. Recently, Dr. Finlay has been looking at the effect of prescription requirements for pseudoephedrine on methamphetamine labs and use of methamphetamine. He received a grant from the Robert Wood Johnson Foundation to measure whether quantity restrictions, electronic tracking, or requiring a doctor’s prescription for pseudoephedrine could ultimately lower the production and use of methamphetamine.
He will be presenting “Willingness-to-Pay for Pharmaceutical Retail Convenience: Evidence from a Contingent Choice Experiment,” which is joint work with Charles Stoecker and Scott Cunningham.
